In recent studies, circulating fractalkine was shown to correlate significantly with serum triglycerides and to be a predictor of the development of metabolic syndrome [14], but its association with type 2 diabetes mellitus is ambiguous [15, 16]. The gene discussed is CX3CL1; the disease is metabolic syndrome.